link: http://ift.tt/1jaUDvL
Hot And Trending...
Trending
- Gold Scarcity in Perspective as "Peak Gold" Looms @SchiffGold http://t.co/bwWA5ADRgn
- It’s Time to Give a Little Thought to Silver https://t.co/6dgAkpzwVk @SchiffGold
- The Fed continues to suggest it wants to raise rates, but the reality is it can't. https://t.co/vpct5j2EzF
- Dow Jones down 6% from its highs & falling fast. How much more will it fall before the Fed stops pretending the data supports a rate hike?
- Had the same 2% inflation assumption used to calculate Q1 #GDP been applied to Q2, the reported growth rate would have been just 1.6%!
- To save the stock market while pretending the "recovery" in still on track, the #Fed used low oil prices as its excuse to turn more dovish.
- The tax code itself creates incentives, and tax cuts can help change those incentives in positive ways that boost growth. http://bit.ly/2B7pwia
- Malinvestment and the Austrian Business Cycle, as explained by Yogi Berra
- Khrushchev: Economics Does Not Respect One's Wishes
- If #Trump really wants to reduce America's trade deficit he needs to slash regulations and massively reduce government spending, including entitlements. That will free up resources to investment in plant, equipment and worker training that will improve our global competitiveness.
Wednesday, September 23, 2015
CEO who raised price of drug by 5000%
I know everyone is hating on this guy, but here is my view on the whole thing. So yeah this guy may be a prick, but from purely an economic sense, what he did might not be so terrible. The patent that Turing Pharmaceuticals purchased is for Daraprim, and from what I know, the patent is actually expired, all he bought was the right to sell the branded drug. No one is producing it generically - yet. With the massive price hike surely some pharmaceutical companies will come in with generic versions of Daraprim and undercut Turing's prices and increase supply until there is competitive equilibrium. What do you think?